American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

AHPA partners with CRN, CHPA and UNPA to produce this unique advocacy opportunity

More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 

AHPA presents at 2019 NIH ODS Dietary Supplement Research Practicum

AHPA presents at 2019 NIH ODS Dietary Supplement Research Practicum

Dr. Zimmermann highlights industry actions to ensure safe and high-quality herbal supplements to medical professionals and researchers

AHPA Chief Information Analyst Merle Zimmermann, Ph.D. presented last week at the Mary Frances Picciano Dietary Supplement Research Practicum held by the Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) campus in Bethesda, MD.
AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

McGuffin recommends FDA issue interim final rule with an accelerated effective date

American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.
AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA provides expertise in hemp-CBD, regulatory initiatives, pesticide residues, NDIs and food allergens

U.S. increases and proposes expansion of tariffs on Chinese imports

China announces additional tariffs on any plant mainly used as a spice

The U.S. Trade Representative (USTR) announced on May 9 that it increased tariffs on approximately $200 billion worth of Chinese imports initially identified in September 2018 from 10 percent to 25 percent.

AHPA urges specificity in OEHHA review of scientific data on cannabis

Scientific review should be specific to route of consumption and part of the plant

In a letter to California’s Office of Environmental Health Hazard Assessment (OEHHA), AHPA strongly recommends that the office ensures that the Developmental and Reproductive Toxicant Identification Committee (DARTIC) sufficiently differentiates between the parts of the cannabis plant and the route of exposure when it reviews scientific literature to determine if certain cannabis articles should be listed under Proposition 65 as causing reproductive toxicity.
IADSA update on international supplement regulations

IADSA update on international supplement regulations

IADSA May 2019 Newsflash

China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

Proposition 65 definition of 'nickel (soluble compounds)' posted

OEHHA action may require warnings by Oct. 26, 2019

California's Office of Environmental Health Hazard Assessment (OEHHA) on May 2, 2019 posted a definition of “nickel (soluble compounds)” to clarify the scope of the agency’s listing last October of these compounds as chemicals known to the state to cause reproductive toxicity for purposes of Proposition 65.

AHPA adopts Guidance Policy on supplements and foods containing hemp and hemp-derived CBD

Supplements or foods that contain hemp or CBD should be manufactured in compliance with applicable federal regulations

The American Herbal Products Association (AHPA) has adopted a new Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD) to help ensure the industry complies with existing regulations.
AHPA participates in USP Botanical Dietary Supplements and Herbal Medicines Expert Committee Meetings

AHPA participates in USP Botanical Dietary Supplements and Herbal Medicines Expert Committee Meetings

Updates from Food Ingredients Expert Committee, Cannabis Expert Panel, Probiotics Expert Panel, Nomenclature subcommittee

AHPA Chief Science Officer Holly E. Johnson, Ph.D., represented AHPA member interests at a meeting of the U.S. Pharmacopeial (USP) Convention's Botanical Dietary Supplements and Herbal Medicines Expert Committee held March 26-27.
RSS
12345678910 Last

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.